BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 15634226)

  • 1. The case for a central nervous system (CNS) origin for the Schwann cells that remyelinate CNS axons following concurrent loss of oligodendrocytes and astrocytes.
    Blakemore WF
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):1-10. PubMed ID: 15634226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial cell transplants that are subsequently rejected can be used to influence regeneration of glial cell environments in the CNS.
    Blakemore WF; Crang AJ; Franklin RJ; Tang K; Ryder S
    Glia; 1995 Feb; 13(2):79-91. PubMed ID: 7649617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination.
    Mothe AJ; Tator CH
    Exp Neurol; 2008 Sep; 213(1):176-90. PubMed ID: 18586031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do central nervous system axons remyelinate?
    Nait-Oumesmar B; Lachapelle F; Decker L; Baron-Van Evercooren A
    Pathol Biol (Paris); 2000 Feb; 48(1):70-9. PubMed ID: 10729914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The remyelinating potential and in vitro differentiation of MOG-expressing oligodendrocyte precursors isolated from the adult rat CNS.
    Crang AJ; Gilson JM; Li WW; Blakemore WF
    Eur J Neurosci; 2004 Sep; 20(6):1445-60. PubMed ID: 15355312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boundary cap cells are highly competitive for CNS remyelination: fast migration and efficient differentiation in PNS and CNS myelin-forming cells.
    Zujovic V; Thibaud J; Bachelin C; Vidal M; Coulpier F; Charnay P; Topilko P; Baron-Van Evercooren A
    Stem Cells; 2010 Mar; 28(3):470-9. PubMed ID: 20039366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors.
    Blakemore WF; Gilson JM; Crang AJ
    Exp Neurol; 2003 Dec; 184(2):955-63. PubMed ID: 14769388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells.
    Groves AK; Barnett SC; Franklin RJ; Crang AJ; Mayer M; Blakemore WF; Noble M
    Nature; 1993 Apr; 362(6419):453-5. PubMed ID: 8464477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lines of glial precursor cells immortalised with a temperature-sensitive oncogene give rise to astrocytes and oligodendrocytes following transplantation into demyelinated lesions in the central nervous system.
    Trotter J; Crang AJ; Schachner M; Blakemore WF
    Glia; 1993 Sep; 9(1):25-40. PubMed ID: 8244529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin-axon relationships established by rat vagal Schwann cells deep to the brainstem surface.
    Fraher JP; Rossiter JP
    J Comp Neurol; 1991 Feb; 304(2):253-60. PubMed ID: 2016420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polysialylated neural cell adhesion molecule-positive CNS precursors generate both oligodendrocytes and Schwann cells to remyelinate the CNS after transplantation.
    Keirstead HS; Ben-Hur T; Rogister B; O'Leary MT; Dubois-Dalcq M; Blakemore WF
    J Neurosci; 1999 Sep; 19(17):7529-36. PubMed ID: 10460259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remyelination in the central nervous system and the peripheral nervous system.
    Ludwin SK
    Adv Neurol; 1988; 47():215-54. PubMed ID: 3278518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remyelination of dorsal column axons by endogenous Schwann cells restores the normal pattern of Nav1.6 and Kv1.2 at nodes of Ranvier.
    Black JA; Waxman SG; Smith KJ
    Brain; 2006 May; 129(Pt 5):1319-29. PubMed ID: 16537565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of myelin-forming cells as candidates for therapeutic transplantation in demyelinated CNS axons].
    Imaizumi T; Lankford KL; Kocsis JD; Sasaki M; Akiyama Y; Hashi K
    No To Shinkei; 2000 Jul; 52(7):609-15. PubMed ID: 10934721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in the morphology of Wallerian degeneration in the central nervous system (CNS) and peripheral nervous system (PNS) and its effect on regeneration.
    Wisniewski HM
    Birth Defects Orig Artic Ser; 1983; 19(4):389-95. PubMed ID: 6871406
    [No Abstract]   [Full Text] [Related]  

  • 16. Differentiation of the O-2A progenitor cell line CG-4 into oligodendrocytes and astrocytes following transplantation into glia-deficient areas of CNS white matter.
    Franklin RJ; Bayley SA; Milner R; Ffrench-Constant C; Blakemore WF
    Glia; 1995 Jan; 13(1):39-44. PubMed ID: 7751054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oligodendrocyte-type-2 astrocyte cell lineage is specialized for myelination.
    Ffrench-Constant C; Raff MC
    Nature; 1986 Sep 25-Oct 1; 323(6086):335-8. PubMed ID: 3531873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat Schwann cell remyelination of demyelinated cat CNS axons: evidence that injection of cell suspensions of CNS tissue results in Schwann cell remyelination.
    Blakemore WF; Crang AJ; Evans RJ; Patterson RC
    Neurosci Lett; 1987 Jun; 77(1):15-9. PubMed ID: 3601212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schwann cell remyelination is restricted to astrocyte-deficient areas after transplantation into demyelinated adult rat brain.
    Shields SA; Blakemore WF; Franklin RJ
    J Neurosci Res; 2000 Jun; 60(5):571-8. PubMed ID: 10820427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocyte-Schwann cell interactions in culture.
    Ghirnikar RS; Eng LF
    Glia; 1994 Aug; 11(4):367-77. PubMed ID: 7960039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.